1
EXHIBIT 4.7
NEITHER THESE SECURITIES NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE
EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR
THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM
REGISTRATION UNDER SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"),
AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE
EXEMPTION FROM THE REGISTRATION REQUIREMENTS THEREUNDER AND IN COMPLIANCE WITH
APPLICABLE STATE SECURITIES OR BLUE SKY LAWS.
NEOTHERAPEUTICS, INC.
CLASS B WARRANT
Warrant No. B-2 Dated: April 6, 2000
NeoTherapeutics, Inc., a Delaware corporation (the "Company"), hereby
certifies that, for value received, Strong River Investments, Inc., or its
registered assigns (the "Holder"), is entitled, subject to the terms and
conditions set forth herein, to purchase from the Company up to a total of
2,000,000 shares of common stock, $.001 par value per share (the "Common
Stock"), of the Company (each such share, a "Warrant Share" and all such shares,
the "Warrant Shares"). Certain terms used herein are defined in Exhibit A
attached hereto:
1. Registration of Warrant. The Company shall register this Warrant,
upon records to be maintained by the Company for that purpose (the "Warrant
Register") in the name of the record Holder hereof from time to time. The
Company may deem and treat the registered Holder of this Warrant as the absolute
owner hereof for the purpose of any exercise hereof or any distribution to the
Holder, and for all other purposes, and the Company shall not be affected by
notice to the contrary.
2. Registration of Transfers and Exchanges.
(a) This Warrant may only be transferred pursuant to an
effective registration statement under the Securities Act, to the Company or
pursuant to an available exemption from or in a transaction not subject to the
registration requirements of the Securities Act. In connection with any transfer
of this Warrant other than pursuant to an effective registration
Class B Warrant
2
statement or to the Company, the Company may require the transferor thereof to
provide to the Company an opinion of counsel selected by the transferor, the
form and substance of which opinion shall be reasonably satisfactory to the
Company, to the effect that such transfer does not require registration of such
Warrant under the Securities Act. Holder agrees to the imprinting, so long as is
required by this Section 2(a), of a legend substantially similar to that first
above written on any New Warrant (as defined below). Any such transferee shall
agree in writing to be bound by the terms of this Warrant and shall have the
rights of Holder under this Warrant. The Company shall register the transfer of
any portion of this Warrant in the Warrant Register, upon surrender of this
Warrant, with the Form of Assignment attached hereto duly completed and signed,
to the Transfer Agent or to the Company at its address for notice set forth in
Section 11. Upon any such registration or transfer, a new warrant to purchase
Common Stock, in substantially the form of this Warrant (any such new warrant, a
"New Warrant"), evidencing the portion of this Warrant so transferred shall be
issued to the transferee and a New Warrant evidencing the remaining portion of
this Warrant not so transferred, if any, shall be issued to the transferring
Holder. The acceptance of the New Warrant by the transferee thereof shall be
deemed the acceptance of such transferee of all of the rights and obligations of
a holder of a Warrant.
(b) This Warrant is exchangeable, upon the surrender hereof by
the Holder to the Company at its address for notice set forth in Section 11 for
one or more New Warrants, evidencing in the aggregate the right to purchase the
number of Warrant Shares which may then be purchased hereunder. Any such New
Warrant will be dated the date of such exchange.
3. Duration, Exercise and Redemption of Warrants.
(a) Company Call Option.
(i) Subject to the terms and conditions set forth herein, prior to
2:30 p.m. (New York City time) on any Trading Day (as defined in Exhibit A)
during the period between the Effective Date (as defined in Exhibit A) and the
Trading Day immediately following the second year anniversary of the Effective
Date (the "Expiration Date"), the Company may deliver written notices to the
Holder (each, a "Call Notice" and the Trading Day a Call Notice is delivered, a
"Delivery Date"), of the Company's election to call, for a price of $.0005 per
Warrant Share, a portion of this Warrant as further described herein; provided
that such price shall be adjusted to reflect any adjustment in the number of
Warrant Shares issuable hereunder, so that the maximum aggregate redemption
price shall continue to be $1,000. Notwithstanding anything to the contrary set
forth in this Warrant: (1) a Call Notice may not apply to a number of Warrant
Shares in excess of 15% of the average trading volume of the Common Stock for
the two Trading Days immediately preceding the Delivery Date, (2) no Call Notice
may be delivered until the expiration of the Call Expiration Time (as defined
below) for the immediately preceding Call Notice, (3) a Call Notice may indicate
that if the Exercise Price (as defined herein) applicable to an exercise of this
Warrant pursuant to such Call Notice shall be lower than a dollar amount
designated by the Company in such Call Notice (such dollar amount, a "Floor
Price"), then, at the option of the
-2-
Class B Warrant
3
Holder: (A) the Exercise Price shall, exclusively for the purpose of such Call
Notice, equal the Floor Price or (B) such Call Notice shall be null and void ab
initio, provided, that a Floor Price must be less than 90% of the Per Share
Market Value on the Trading Day preceding the Delivery Date and (4) no Call
Notice may be delivered unless the conditions set forth in Section 3(a)(iii)
have been either satisfied by the Company or waived by the Holder.
(ii) The portion of this Warrant subject to a Call Notice will be
canceled and of no further effect from and after 5:30 p.m. (New York City time)
on the Trading Day following Delivery Date (the "Call Expiration Time"), unless
between the Delivery Date and the Call Expiration Time the Holder notifies the
Company in writing that it will exercise this Warrant to acquire the number of
Warrant Shares subject to such Call Notice at the Exercise Price per share set
forth in Section 3(c). Such exercise shall be in accordance with Section
3(b)(ii).
(iii) The right of the Company to deliver a Call Notice is subject
to the satisfaction or waiver by the Holder, at or before the applicable Call
Expiration Time, of each of the following conditions (and, if after delivery
thereof and on the applicable Exercise Date, any of the following conditions
shall cease to be met, such Call Notice, at the option of the Holder, shall be
null and void ab initio):
(a) The representations and warranties of the Company
contained in the Purchase Agreement shall be true and
correct as of each of the applicable Delivery Date
and Call Expiration Time, as though first made on and
as of such Delivery Date and Call Expiration Time
(other than representations and warranties which
relate to a specific date (which shall not include
representations and warranties relating to the "date
hereof") which representations and warranties shall
be true as of such specific date);
(b) The Company shall have performed, satisfied and
complied in all material respects with all covenants
(including timely delivery of Warrant Shares in
accordance with Section 3(a)), agreements and
conditions of the Transaction Documents (as defined
in the Purchase Agreement) to be performed, satisfied
or complied with by the Company at or prior to the
applicable Delivery Date and Call Expiration Time;
(c) The Underlying Shares Registration Statement (as defined
in Exhibit A) shall be effective on the Delivery Date,
not subject to any stop order or suspension;
(d) No statute, rule, regulation, executive order, decree,
ruling or injunction shall have been enacted, entered,
promulgated or
-3-
Class B Warrant
4
endorsed by any court or governmental authority of
competent jurisdiction and in force on the Delivery Date
which prohibits the consummation of any of the
transactions contemplated by the Transaction Documents;
(e) Since the Closing Date (as defined in the Purchase
Agreement), no event or series of events which
reasonably would be expected to have or result in a
Material Adverse Effect (as defined in the Purchase
Agreement) and no Change of Control Transaction (as
defined in Exhibit A) shall have occurred;
(f) Since the Closing Date, trading in the Common Stock
shall not have been suspended by the Securities and
Exchange Commission for a period in excess of five
consecutive Trading Days or ten Trading Days in the
aggregate (which need not be consecutive Trading
Days), except for any suspensions of trading of not
more than one Trading Day solely to permit
dissemination of material information regarding the
Company;
(g) On the Delivery Date, the Common Stock shall be trading
on the Nasdaq Small Cap Market ("NASDAQ"), or on the
Nasdaq National Market, New York Stock Exchange or
American Stock Exchange (each, a "Subsequent Market");
(h) No approval of the shareholders of the Company shall be
required under the rules of the Nasdaq Stock Market or
any other Subsequent Market on which the Common Stock is
traded or listed for trading in order to issue the
number of Warrant Shares indicated in the applicable
Call Notice at the Exercise Price;
(i) For the five Trading Days immediately preceding the
applicable Delivery Date, the average daily trading
volume of the Common Stock on the NASDAQ as reported by
Bloomberg L.P., shall be at least 20,000 shares and the
average of the Per Share Market Values (as defined in
Exhibit A) for such five Trading Days shall be at least
$5.00; and
(j) The Call Notice at issue would not result in a violation
of Section 3(e).
(b) Exercise By Holder.
-4-
Class B Warrant
5
(i) At any time on and after the Effective Date (and in the case of
an election to purchase which is not in response to a Call Notice, if earlier,
the 90th day after the date of this Warrant) and prior to 5:30 p.m. (New York
City time) on the Expiration Date, the Holder shall be entitled to purchase all
or a portion of the Warrant Shares which have not been previously issued and
with respect to which this Warrant has not been previously redeemed or canceled
in accordance with the terms hereof.
(ii) The Holder may purchase Warrant Shares hereunder by delivering
to the Company, at its address for notice set forth in Section 11, a completed
Form of Election to Purchase in the form attached hereto, together with the
payment of the Exercise Price multiplied by the number of Warrant Shares
indicated therein. An "Exercise Date" means the date of the delivery (which may
be made via facsimile) of the Form of Election to Purchase and applicable
Exercise Price.
(iii) After the end of the week in which the Company receives one or
more Forms of Election to Purchase and the applicable Exercise Price, the
Company shall promptly (but in no event later than three Trading Days following
the end of such week) issue or cause to be issued and cause to be delivered to
or upon the written order of the Holder and in such name or names as the Holder
may designate, a certificate for the Warrant Shares issuable upon such exercise,
free of restrictive legends except as required by the Purchase Agreement,
provided, that, if in any week the Company shall receive one or more Forms of
Election to Purchase for the purchase of in excess of 30,000 Warrant Shares, the
Company shall issue such certificate no later than the third Trading Day
following the date of the delivery of the applicable Form of Election to
Purchase which resulted in the purchase of in excess of 30,000 Warrant Shares.
(A) If the Company fails to deliver to the Holder the
certificate or certificates pursuant to this Section
within the time specified in above, the Holder shall be
entitled by written notice to the Company at any time on
or before its receipt of such certificate or
certificates thereafter, to rescind such exercise.
(B) In addition to the rights set forth in (A) above, if
the Company fails to deliver to the Holder such
certificate or certificates pursuant to this Section
within the time specified in above, and if after such
time the Holder purchases (in an open market
transaction or otherwise) Common Stock to deliver in
satisfaction of a sale by such Holder of the Warrant
Shares which the Holder anticipated receiving upon
such exercise (a "Buy-In"), then the Company shall
(1) pay in cash to the Holder the amount by which
(x) the Holder's total purchase price (including
brokerage commissions, if any) for the Common Stock
so purchased exceeds (y) the product of (i) the
aggregate number of Warrant Shares that such Holder
anticipated receiving from the exercise at issue
multiplied by (ii) the Per Share Market
-5-
Class B Warrant
6
Value on the Exercise Date and (2) at the option of
the Holder, either rescind the exercise at issue or
deliver to the Holder the number of Warrant Shares
that would have been issued had the Company timely
complied with its delivery requirements under this
Section. For example, if the Holder purchases Common
Stock having a total purchase price of $11,000 to
cover a Buy-In with respect to an attempted exercise
with respect to which the Per Share Market Value on
the Exercise Date was a total of $10,000, the Company
shall be required to pay the Holder $1,000. The
Holder shall provide the Company written notice
indicating the amounts payable to the Holder in
respect of the Buy-In.
(c) Exercise Price.
The "Exercise Price" applicable to an exercise following a Call
Notice under Section 3(a) shall equal the lower of (i) $33.75(subject to
equitable adjustment for stock splits, reverse splits, combinations and other
similar events) and (ii) 97% of the Per Share Market Value on the Trading Day
immediately following the applicable Delivery Date. The Exercise Price
applicable to an exercise pursuant to Section 3(b)(i) that is not in response to
a Call Notice shall equal $33.75 (subject to equitable adjustment for stock
splits, reverse splits, combinations and other similar events). The Exercise
Price shall be subject to adjustment in accordance with Section 8.
(d) Redemption at Option of Company.
On and after the 6th month anniversary of the Effective Date, the
Company may redeem all or any portion of this Warrant which has not been
previously exercised and for which no Form of Election to Purchase shall been
received by delivery to the Holder of a notice of such redemption, together with
the redemption price equal to $.05 per Warrant Share to be redeemed, payable by
the third Trading Day following the delivery of such notice by the Company;
provided that the redemption price shall be adjusted to reflect any adjustment
in the number of Warrant Shares issuable hereunder, so that the maximum
aggregate redemption price shall continue to be $100,000. Interest shall accrue
on the unpaid portion of such redemption price at the rate of 10% per annum
beginning on such third Trading Day.
(e) Certain Exercise Restrictions.
(i) The Company may not issue Warrant Shares upon exercise of this
Warrant, in response to a Call Notice in excess of the product of (x) 50% and
(y)19.9999% of the shares of Common Stock outstanding on the Closing Date, less
an amount equal to the aggregate number of shares of Common Stock issued (A)
upon conversion of the Company's 5% Subordinated Convertible Debentures
originally issued to the Holder, and (B) upon any exercise of this Warrant, in
response to a Call Notice unless the Company shall have obtained the approval of
the
-6-
Class B Warrant
7
stockholders of the Company as required under the rules of the Nasdaq Stock
Market or such other exchange or trading facility on which the Common Stock is
traded or listed for trading for such issuance. In the event of any subdivision,
transfer or exchange of this Warrant, the limitation contained in this Section
3(e)(i) shall be appropriately adjusted to ensure that in no event shall the
Company issue, upon any exercise of this Warrant in response to a Call Notice,
in excess of the product of (x) 50% and (y) 19.999% of the shares of Common
Stock outstanding on the Closing Date, less an amount equal to the aggregate
number of shares of Common Stock issued (A) upon conversion of the Company's 5%
Subordinated Convertible Debentures originally issued to the Holder, and (B)
upon any exercise of this Warrant, in response to a Call Notice unless the
Company shall have obtained the approval of the stockholders of the Company as
required under the rules of the Nasdaq Stock Market or such other exchange or
trading facility on which the Common Stock is traded or listed for trading for
such issuance.
(ii) A Holder may not exercise this Warrant to the extent such
exercise would result in the Holder, together with any affiliate thereof,
beneficially owning (as determined in accordance with Section 13(d) of the
Securities Exchange Act of 1934, as amended (the "Exchange Act") and the rules
promulgated thereunder) in excess of 9.999% of the then issued and outstanding
shares of Common Stock, including shares issuable upon such exercise and held by
such Holder after application of this Section. Since the Holder will not be
obligated to report to the Company the number of shares of Common Stock it may
hold at the time of an exercise hereunder, unless the exercise at issue would
result in the issuance of shares of Common Stock in excess of 9.999% of the then
outstanding shares of Common Stock without regard to any other shares which may
be beneficially owned by the Holder or an affiliate thereof, the Holder shall
have the authority and obligation to determine whether the restriction contained
in this Section will limit any particular exercise hereunder and to the extent
that the Holder determines that the limitation contained in this Section
applies, the determination of which portion of this Warrant is exercisable shall
be the responsibility and obligation of the Holder. If the Holder has delivered
a Form of Election to Purchase for a number of Warrant Shares that, without
regard to any other shares that the Holder or its affiliates may beneficially
own, would result in the issuance in excess of the permitted amount hereunder,
the Company shall notify the Holder of this fact and shall honor the exercise
for the maximum portion of this Warrant permitted to be exercised on such Date
of Exercise in accordance with the periods described herein and, at the option
of the Holder, either keep the portion of the Warrant tendered for exercise in
excess of the permitted amount hereunder for future exercises or return such
excess portion of the Warrant to the Holder. The provisions of this Section may
be waived by a Holder (but only as to itself and not to any other Holder) upon
not less than 61 days prior notice to the Company.
4. Piggyback Registration Rights. During the Effectiveness Period
(as defined in the Registration Rights Agreement, of even date herewith, between
the Company and the original Holder), the Company may not file any registration
statement with the Securities and Exchange Commission (other than registration
statements of the Company filed on Form S-8 or Form S-4, each as promulgated
under the Securities Act, pursuant to which the Company is registering
securities pursuant to a Company employee benefit plan or pursuant to a merger,
-7-
Class B Warrant
8
acquisition or similar transaction including supplements thereto, but not
additionally filed registration statements in respect of such securities) at any
time when there is not an effective registration statement covering the resale
of the Warrant Shares and naming the Holder as a selling stockholder thereunder,
unless the Company provides the Holder with not less than 20 days notice of its
intention to file such registration statement and provides the Holder the option
to include any or all of the applicable Warrant Shares therein. The piggyback
registration rights granted to the Holder pursuant to this Section shall
continue until all of the Holder's Warrant Shares have been sold in accordance
with an effective registration statement or upon the expiration of the Effective
Period. The Company will pay all registration expenses in connection therewith.
5. Payment of Taxes. The Company will pay all documentary stamp
taxes attributable to the issuance of Warrant Shares upon the exercise of this
Warrant; provided, however, that the Company shall not be required to pay any
tax which may be payable in respect of any transfer involved in the registration
of any certificates for Warrant Shares or Warrants in a name other than that of
the Holder. The Holder shall be responsible for all other tax liability that may
arise as a result of holding or transferring this Warrant or receiving Warrant
Shares upon exercise hereof.
6. Replacement of Warrant. If this Warrant is mutilated, lost,
stolen or destroyed, the Company shall issue or cause to be issued in exchange
and substitution for and upon cancellation hereof, or in lieu of and
substitution for this Warrant, a New Warrant, but only upon receipt of evidence
reasonably satisfactory to the Company of such loss, theft or destruction and
indemnity, if requested, satisfactory to it. Applicants for a New Warrant under
such circumstances shall also comply with such other reasonable regulations and
procedures and pay such other reasonable charges as the Company may prescribe.
7. Reservation of Warrant Shares. The Company covenants that it will
at all times reserve and keep available out of the aggregate of its authorized
but unissued Common Stock, solely for the purpose of enabling it to issue
Warrant Shares upon exercise of this Warrant as herein provided, the number of
Warrant Shares which are then issuable and deliverable upon the exercise of this
entire Warrant, free from preemptive rights or any other actual contingent
purchase rights of persons other than the Holder (taking into account the
adjustments and restrictions of Section 8). The Company covenants that all
Warrant Shares that shall be so issuable and deliverable shall, upon issuance
and the payment of the applicable Exercise Price in accordance with the terms
hereof, be duly and validly authorized, issued and fully paid and nonassessable.
8. Certain Adjustments.
(a) In case of any reclassification of the Common Stock or any
compulsory share exchange pursuant to which the Common Stock is converted into
other securities, cash or property, then the Holder shall have the right
thereafter to exercise this Warrant only into the shares of stock and other
securities and property receivable upon or deemed to be
-8-
Class B Warrant
9
held by holders of Common Stock following such reclassification or share
exchange, and the Holder shall be entitled upon such exercise to receive such
amount of securities or property equal to the amount of Warrant Shares such
Holder would have been entitled to had such Holder exercised this Warrant
immediately prior to such reclassification or share exchange.
(b) In case of the closing of any (1) merger or consolidation
of the Company with or into another Person, or (2) sale by the Company of more
than one-half of the assets of the Company (on a book value basis) in one or a
series of related transactions, or (3) tender or other offer or exchange
(whether by the Company or another Person) pursuant to which holders of Common
Stock are permitted to tender or exchange their shares for other securities,
stock, cash or property of the Company or another Person; then the Holder shall
have the right thereafter to (A) exercise this Warrant for the shares of stock
and other securities, cash and property receivable upon or deemed to be held by
holders of Common Stock following such merger, consolidation or sale, and the
Holder shall be entitled upon exercise of this Warrant to receive such amount of
securities, cash and property as the Common Stock for which this Warrant could
have been exercised immediately prior to such merger, consolidation or sales
would have been entitled, or (B) in the event of an exchange or tender offer or
other transaction contemplated by clause (3) of this Section, tender or exchange
this Warrant for such securities, stock, cash and other property receivable upon
or deemed to be held by holders of Common Stock that have tendered or exchanged
their shares of Common Stock following such tender or exchange, and the Holder
shall be entitled upon such exchange or tender to receive such amount of
securities, cash and property as the shares of Common Stock for which this
Warrant could have been exercised immediately prior to such tender or exchange
would have been entitled as would have been issued. The terms of any such
merger, sale, consolidation, tender or exchange shall include such terms so as
continue to give the Holder the right to receive the securities, cash and
property set forth in this Section upon any conversion or redemption following
such event. This provision shall similarly apply to successive such events.
(c) All calculations under this Section 8 shall be made to the
nearest cent or the nearest 1/100th of a share, as the case may be.
(d) If (i) the Company shall declare a dividend (or any other
distribution) on its Common Stock; or (ii) the Company shall declare a special
nonrecurring cash dividend on or a redemption of its Common Stock; or (iii) the
Company shall authorize the granting to all holders of the Common Stock rights
or warrants to subscribe for or purchase any shares of capital stock of any
class or of any rights; or (iv) the approval of any stockholders of the Company
shall be required in connection with any reclassification of the Common Stock,
any consolidation or merger to which the Company is a party, any sale or
transfer of all or substantially all of the assets of the Company, or any
compulsory share exchange whereby the Common Stock is converted into other
securities, cash or property; or (v) the Company shall authorize the voluntary
dissolution, liquidation or winding up of the affairs of the Company, then the
Company shall cause to be mailed to each Holder at their last addresses as they
shall appear upon the Warrant Register, at least 30 calendar days prior to the
applicable record or effective date
-9-
Class B Warrant
10
hereinafter specified, a notice stating (x) the date on which a record is to be
taken for the purpose of such dividend, distribution, redemption, rights or
warrants, or if a record is not to be taken, the date as of which the holders of
Common Stock of record to be entitled to such dividend, distributions,
redemption, rights or warrants are to be determined or (y) the date on which
such reclassification, consolidation, merger, sale, transfer or share exchange
is expected to become effective or close, and the date as of which it is
expected that holders of Common Stock of record shall be entitled to exchange
their shares of Common Stock for securities, cash or other property deliverable
upon such reclassification, consolidation, merger, sale, transfer, share
exchange, dissolution, liquidation or winding up, provided, that the failure to
mail such notice or any defect therein or in the mailing thereof shall not
affect the validity of the corporate action required to be specified in such
notice.
9. Payment of Exercise Price. The Holder shall pay the Exercise
Price for Warrant Shares purchased hereunder by delivery of immediately
available funds.
10. Fractional Shares. The Company shall not be required to issue or
cause to be issued fractional Warrant Shares on the exercise of this Warrant.
The number of full Warrant Shares which shall be issuable upon the exercise of
this Warrant shall be computed on the basis of the aggregate number of Warrant
Shares purchasable on exercise of this Warrant so presented. If any fraction of
a Warrant Share would, except for the provisions of this Section, be issuable on
the exercise of this Warrant, the Company shall pay an amount in cash equal to
the Exercise Price multiplied by such fraction.
11. Notices. Any and all notices or other communications or
deliveries hereunder shall be in writing and shall be deemed given and effective
on the earliest of (i) the date of transmission, if such notice or communication
is delivered via facsimile at the facsimile telephone number specified in this
Section prior to 8:00 p.m. (New York City time) on a business day, (ii) the
business day after the date of transmission, if such notice or communication is
delivered via facsimile at the facsimile telephone number specified in this
Section later than 8:00 p.m. (New York City time) on any date and earlier than
11:59 p.m. (New York City time) on such date, (iii) the business day following
the date of mailing, if sent by nationally recognized overnight courier service,
or (iv) if sent other than by the methods set forth in (i)-(iii) of this
section, upon actual receipt by the party to whom such notice is required to be
given. The addresses for such communications shall be: (i) if to the Company, to
157 Technology Drive, Irvine, CA 92618, Attention: Chief Financial Officer, or
to Facsimile No. (949) 788-6706, or (ii) if to the Holder, to the Holder at the
address or facsimile number appearing on the Warrant Register or such other
address or facsimile number as the Holder may provide to the Company in
accordance with this Section.
12. Warrant Agent. The Company shall serve as warrant agent under
this Warrant. Upon thirty (30) days' notice to the Holder, the Company may
appoint a new warrant agent. Any corporation into which the Company or any new
warrant agent may be merged or any corporation resulting from any consolidation
to which the Company or any new warrant agent
-10-
Class B Warrant
11
shall be a party or any corporation to which the Company or any new warrant
agent transfers substantially all of its corporate trust or shareholders
services business shall be a successor warrant agent under this Warrant without
any further act. Any such successor warrant agent shall promptly cause notice of
its succession as warrant agent to be mailed (by first class mail, postage
prepaid) to the Holder at the Holder's last address as shown on the Warrant
Register.
13. Miscellaneous.
(a) This Warrant shall be binding on and inure to the benefit
of the parties hereto and their respective successors and assigns. This Warrant
may be amended only in writing signed by the Company and the Holder and their
successors and assigns.
(b) Subject to Section 13(a), above, nothing in this Warrant
shall be construed to give to any person or corporation other than the Company
and the Holder any legal or equitable right, remedy or cause under this Warrant.
This Warrant shall inure to the sole and exclusive benefit of the Company and
the Holder.
(c) The corporate laws of the State of Delaware shall govern
all issues concerning the relative rights of the Company and its stockholders.
All other questions concerning the construction, validity, enforcement and
interpretation of this Warrant shall be governed by and construed and enforced
in accordance with the internal laws of the State of New York, without regard to
the principles of conflicts of law thereof. The Company and the Holder hereby
irrevocably submit to the exclusive jurisdiction of the state and federal courts
sitting in the City of New York, borough of Manhattan, for the adjudication of
any dispute hereunder or in connection herewith or with any transaction
contemplated hereby or discussed herein, and hereby irrevocably waives, and
agrees not to assert in any suit, action or proceeding, any claim that it is not
personally subject to the jurisdiction of any such court, or that such suit,
action or proceeding is improper. Each of the Company and the Holder hereby
irrevocably waives personal service of process and consents to process being
served in any such suit, action or proceeding by receiving a copy thereof sent
to the Company at the address in effect for notices to it under this instrument
and agrees that such service shall constitute good and sufficient service of
process and notice thereof. Nothing contained herein shall be deemed to limit in
any way any right to serve process in any manner permitted by law.
(d) The headings herein are for convenience only, do not
constitute a part of this Warrant and shall not be deemed to limit or affect any
of the provisions hereof.
(e) In case any one or more of the provisions of this Warrant
shall be invalid or unenforceable in any respect, the validity and
enforceability of the remaining terms and provisions of this Warrant shall not
in any way be affected or impaired thereby and the parties will attempt in good
faith to agree upon a valid and enforceable provision which shall be a
commercially reasonable substitute therefor, and upon so agreeing, shall
incorporate such substitute provision in this Warrant.
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK,
SIGNATURE PAGE FOLLOWS]
Class B Warrant
-11-
12
IN WITNESS WHEREOF, the Company has caused this Warrant to be duly
executed by its authorized officer as of the date first indicated above.
NEOTHERAPEUTICS, INC.
By: /s/ Samuel Gulko
------------------------------
Name: Samuel Gulko
Title: Chief Financial Officer
13
FORM OF ELECTION TO PURCHASE
(To be executed by the Holder to exercise the right to purchase shares of Common
Stock under the foregoing Warrant)
To NeoTherapeutics, Inc.:
In accordance with the Warrant enclosed with this Form of Election to
Purchase, the undersigned hereby irrevocably elects to purchase _____________
shares of common stock, $.001 par value per share, of NeoTherapeutics, Inc. (the
"Common Stock") and , if such Holder is not utilizing the cashless exercise
provisions set forth in this Warrant, encloses herewith $________ in cash,
certified or official bank check or checks, which sum represents the aggregate
Exercise Price (as defined in the Warrant) for the number of shares of Common
Stock to which this Form of Election to Purchase relates, together with any
applicable taxes payable by the undersigned pursuant to the Warrant.
The undersigned requests that certificates for the shares of Common Stock
issuable upon this exercise be issued in the name of
PLEASE INSERT SOCIAL SECURITY OR TAX IDENTIFICATION NUMBER
________________________________________________________________________________
________________________________________________________________________________
(Please print name and address)
________________________________________________________________________________
________________________________________________________________________________
If the number of shares of Common Stock issuable upon this exercise shall
not be all of the shares of Common Stock which the undersigned is entitled to
purchase in accordance with the enclosed Warrant, the undersigned requests that
a New Warrant (as defined in the Warrant) evidencing the right to purchase the
shares of Common Stock not issuable pursuant to the exercise evidenced hereby be
issued in the name of and delivered to:
________________________________________________________________________________
(Please print name and address)
________________________________________________________________________________
________________________________________________________________________________
Dated: ___________, _____ Name of Holder:
(Print) ________________________________________________________________________
(By:) __________________________________________________________________________
Name:)
(Title:)
(Signature must conform in all
respects to name of holder as
specified on the face of the
Warrant)
Class B Warrant
14
FORM OF ASSIGNMENT
[To be completed and signed only upon transfer of Warrant]
FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers
unto ________________________________ the right represented by the within
Warrant to purchase ____________ shares of Common Stock of NeoTherapeutics, Inc.
to which the within Warrant relates and appoints ________________ attorney to
transfer said right on the books of NeoTherapeutics Inc. with full power of
substitution in the premises.
Dated:
______________,____
______________________________________
(Signature must conform in all respects to name
of holder as specified on the face of the
Warrant)
______________________________________
Address of Transferee
______________________________________
______________________________________
In the presence of:
___________________
Class B Warrant
15
EXHIBIT A
(i) "Business Day" means any day except Saturday, Sunday and any day which
shall be a federal legal holiday or a day on which banking institutions in the
State of New York and the State of California are authorized or required by law
or other governmental action to close.
(ii) "Change of Control Transaction" means the occurrence of any of (i) an
acquisition after the date hereof by an individual or legal entity or "group"
(as described in Rule 13d-5(b)(1) promulgated under the Exchange Act) of
effective control (whether through legal or beneficial ownership of capital
stock of the Company, by contract or otherwise) of in excess of 33% of the
voting securities of the Company, (ii) a replacement at one time or over time of
more than one-half of the members of the Company's board of directors which is
not approved by a majority of those individuals who are members of the board of
directors on the date hereof (or by those individuals who are serving as members
of the board of directors on any date whose nomination to the board of directors
was approved by a majority of the members of the board of directors who are
members on the date hereof), (iii) the merger or consolidation of the Company
with or into another entity that is not wholly-owned by the Company upon the
completion of which the stockholders of the Company immediately before such
merger or consolidation own or control less than 2/3 of the voting securities of
the surviving entity or sale of 50% or more of the assets of the Company in one
or a series of related transactions, or (i) the execution by the Company of an
agreement to which the Company is a party or by which it is bound, providing for
any of the events set forth above in (i), (ii) or (iii).
(iii) "Commission" means the Securities and Exchange Commission.
(iv) "Effective Date" means the date the Underlying Shares Registration
Statement is declared effective by the Commission.
(v) "Per Share Market Value" means on any particular date (a) the closing
bid price per share of Common Stock on such date on the NASDAQ or on such
Subsequent Market on which the shares of Common Stock are then listed or quoted,
or if there is no such price on such date, then the closing bid price on the
NASDAQ or on such Subsequent Market on the date nearest preceding such date, or
(b) if the shares of Common Stock are not then listed or quoted on the NASDAQ or
a Subsequent Market, the closing bid price for a share of Common Stock in the
over-the-counter market, as reported by the National Quotation Bureau
Incorporated or similar organization or agency succeeding to its functions of
reporting prices) at the close of business on such date, or (c) if the shares of
Common Stock are not then reported by the National Quotation Bureau Incorporated
(or similar organization or agency succeeding to its functions of reporting
prices), then the average of the "Pink Sheet" quotes for the relevant conversion
period, as determined in good faith by the Holder, or (d) if the shares of
Common Stock are not then publicly traded the fair market value of a share of
Common Stock as determined by an Appraiser selected in good faith by the Holders
of a majority in interest of the Warrants then outstanding.
(vi) "Purchase Agreement" means the Convertible Debenture Purchase
Agreement dated as of the date hereof, to which the Company and the original
Holder hereof are parties.
Class B Warrant
16
(vii) "Trading Day" means (a) a day on which the shares of Common Stock
are traded on the NASDAQ or on such Subsequent Market on which the shares of
Common Stock are then listed or quoted, or (b) if the shares of Common Stock are
not listed on the NASDAQ or a Subsequent Market, a day on which the shares of
Common Stock are traded in the over-the-counter market, as reported by the OTC
Bulletin Board, or (c) if the shares of Common Stock are not quoted on the OTC
Bulletin Board, a day on which the shares of Common Stock are quoted in the
over-the-counter market as reported by the National Quotation Bureau
Incorporated (or any similar organization or agency succeeding its functions of
reporting prices); provided, however, that in the event that the shares of
Common Stock are not listed or quoted as set forth in (a), (b) and (c) hereof,
then Trading Day shall mean a Business Day.
(viii) "Underlying Shares Registration Statement" shall have the meaning
set forth in the Purchase Agreement.
Class B Warrant